Lantis Laser Inc. (OTC: LLSR) has been rated “Speculative Buy” with a target price of $1.70 by Beacon Equity Research Analyst, Lisa Springer, CFA.
The full report is available at http://www.beaconequityresearch.com/
Anyone interested in receiving alerts regarding Lantis Laser Inc. research should email members@beaconequityresearch.com with “LLSR” in the subject line.
In the report, the analyst writes, “Lantis Laser, Inc. (LLSR) is developing and commercializing advanced technologies for applications in dentistry. The Company has exclusive rights to the application of Optical Coherence Tomography (OCT) technology for dental diagnostic imaging through its license agreements with LightLab Imaging and Lawrence Livermore National Laboratory.”
“LLSR is currently in Phase II development of its first product, the “OCT Dental Imaging System”. The System has an unprecedented high resolution of up to 10 times that oftraditional dental x-rays and is designed to provide early detection of - tooth decay, periodontal disease and microstructural defects in teeth. Early detection allows the dentist to promptly halt or even reverse the progress of the disease using non- or minimally invasive procedures, thus improving outcomes and enhancing the quality of patient care.”
Beacon Equity Research Disclosure
